Triple-negative BC (TNBC), which lacks the expression of ER, PR, and HER2, constitutes 15–20% of BC cases, and has the highest probability of metastasis and the lowest overall survival (OS) among all BC subtypes (6, 7). The gene discussed is ERBB2; the disease is breast cancer.